DNA
HealthcareGinkgo Bioworks Holdings, Inc.
$8.87
+$0.17 (+1.95%)
Jan 5, 2026
Price History (1Y)
Analysis
Ginkgo Bioworks Holdings, Inc. is a biotechnology company listed under the ticker DNA in the healthcare sector. The company operates at a significant scale with 834 employees and has a market capitalization of $537.44 million. Financially, Ginkgo Bioworks Holdings, Inc. reported revenue of $180.61 million for the trailing twelve months (TTM) but incurred a net loss of $339.55 billion during this period. The company's gross margin is 72.7%, while its operating and profit margins are -227.3% and -188.0%, respectively. In terms of returns, Ginkgo Bioworks Holdings, Inc. reported a return on equity (ROE) of -50.0% and a return on assets (ROA) of -15.6%. The company's balance sheet shows $461.86 million in cash and $422.87 million in debt, resulting in a debt-to-equity ratio of 75.54. The company's valuation is characterized by a forward price-to-earnings ratio of -1.11 and an earnings growth rate of N/A for the past year. Ginkgo Bioworks Holdings, Inc.'s revenue growth has declined by 56.4% over the same period, while its dividend yield is N/A.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Visit website →Key Statistics
- Market Cap
- $537.44M
- P/E Ratio
- N/A
- 52-Week High
- $17.58
- 52-Week Low
- $5.00
- Avg Volume
- 1.22M
- Beta
- 1.56
Company Info
- Industry
- Biotechnology
- Exchange
- NYQ
- Country
- United States
- Employees
- 834